Logo

Exiqon ExiLERATE LNA

Jun 30, 2015

Exiqon has launched a quantitative PCR product portfolio, ExiLERATE LNA, enabling real-time PCR analysis of mRNAs and long non-coding RNA. The suite of products supports sample isolation, cDNA generation, real-time PCR amplification, and detection, and is compatible with all major real-time PCR instruments. It includes endogenous controls and supports custom assay design facilitated by an assay design tool called XploreRNA.

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.